Introduction
The double-stranded RNA-dependent protein kinase, PKR, was first characterized as an enzyme important for the establishment of an antiviral state after interferon treatment of cells. PKR is activated by binding to double-stranded RNA formed during viral replication; it phosphorylates the a-subunit of translation factor eIF2, resulting in inhibition of protein synthesis (Barber, 2005; Garcia et al., 2007) . PKR has also been implicated in many additional cellular stress responses and corresponding signal transduction pathways, including the nuclear factor-kB and p38-mitogen-activated protein kinase pathways (reviewed by Barber, 2005; Garcia et al., 2006 Garcia et al., , 2007 . A major role for PKR has recently emerged in the control of apoptosis, following activation of the tumour-suppressor p53 pathway (Yoon et al., 2009) . Inhibition of protein synthesis through eIF2a phosphorylation plays a considerable part in PKR activity (Scheuner et al., 2006; Lee et al., 2007) , but other pathways are most likely also involved (Garcia et al., 2006) .
Depletion of endoplasmic reticulum (ER) calcium stores results in PKR activation (Prostko et al., 1995) , and expression of a dominant-negative mutant of PKR interferes with the ability of ER calcium depletion to reduce translation rates (Srivastava et al., 1995) . The discovery of the PKR-like ER kinase (PERK) (Harding et al., 1999) has cast doubts on the involvement of PKR in the inhibition of protein synthesis caused by depletion of ER calcium stores. However, it has recently been established that PKR is activated in addition to PERK upon induction of ER stress by both thapsigargin and tunicamycin (Onuki et al., 2004; Lee et al., 2007; Singh et al., 2009) .
The translationally controlled tumour protein (TCTP) is a multifunctional protein, which is highly regulated during adaptation of cells to alterations in physiological conditions, such as growth induction, tumorigenesis, stress and apoptosis. TCTP is a highly conserved protein, which is present in all eukaryotic organisms, and many molecular, cellular and indeed extracellular functions have been ascribed to it (Bommer and Thiele, 2004; Telerman and Amson, 2009) . Our laboratory has characterized the microtubule-stabilizing activity of TCTP and mapped its tubulin-binding domain (Gachet et al., 1999) . Ca þ þ -binding activity has been reported for TCTP by several laboratories; however, there are conflicting reports on the precise localization of the Ca þ þ -binding site (Kim et al., 2000; Feng et al., 2007; Graidist et al., 2007) .
Several additional molecular interactions and regulatory functions have been reported for TCTP: (1) the protein binds to the Na þ , K þ -ATPase and inhibits this enzyme (Jung et al., 2004) . This observation is consistent with the demonstration that TCTP overexpression in mice results in systemic hypertension (Kim et al., 2008b) ; (2) TCTP interacts with protein synthesis elongation factor eEF1A and negatively regulates the guanosine-nucleotide-exchange reaction on eEF1A (Cans et al., 2003) ; (3) a study using gene knockdown in Drosophila reported the activity of TCTP as a guanine-nucleotide-exchange factor for the small GTPase, Rheb, and indicated involvement of TCTP in the target of rapamycin (TOR) signalling pathway (Hsu et al., 2007) ; however, recent results from our own (Wang et al., 2008) and two other laboratories (Chen et al., 2007; Rehmann et al., 2008) are not compatible with this conclusion.
TCTP has been implicated in the promotion of cell growth and tumorigenesis, and in protection against apoptosis and other consequences of cell stress (Bommer and Thiele, 2004; Gnanasekar et al., 2009; Telerman and Amson, 2009) . TCTP protein levels are upregulated in cancer cells and in human tumours (Tuynder et al., 2004; Kim et al., 2008a; Ma et al., 2009; Slaby et al., 2009) . Downregulation of TCTP has been implicated in biological models of tumour reversion (Tuynder et al., 2002 (Tuynder et al., , 2004 , and the protein is the target of various anticancer drugs (Tuynder et al., 2004; Efferth, 2005) , of which one has entered a phase-I/II clinical trial (Telerman and Amson, 2009) . TCTP has been proposed as a potential biomarker for lung cancer (Kim et al., 2008a) and for progression of tumorous mycetoma (van de Sande et al., 2006) . Gene-knockout studies have established the importance of TCTP in developmental regulation. Homozygous, TCTP-null mice (Chen et al., 2007; Susini et al., 2008) and dTCTP-null mutants in Drosophila (Hsu et al., 2007) exhibit embryonic lethality. Gene knockdown in Arabidopsis generated a male gametophytic phenotype and developmental alterations (Berkowitz et al., 2008) . Recent reports described the importance of TCTP for the reprogramming of somaticcell nuclei after transfer into oocytes or stem cells (Koziol et al., 2007; Tani et al., 2007) . TCTP (fortilin) has been characterized as an antiapoptotic protein (Li et al., 2001) ; it interacts with other antiapoptotic proteins, Mcl-1 (Zhang et al., 2002; Liu et al., 2005) and Bcl-xL . This cytoprotective role of TCTP is consistent with the recently reported antioxidant function of filarial TCTP (Gnanasekar and Ramaswamy, 2007) , and with observations that TCTP levels are highly regulated in various cell-stress conditions (Schmidt et al., 2007) . The importance of TCTP in preventing apoptosis in regulatory T cells and in the prevention of vascular inflammation, has recently been shown in a mouse model (Xiong et al., 2008) . TCTP has also been extensively characterized as a histamine-release factor in the context of allergic diseases (Vonakis et al., 2008) .
We have previously studied the mechanism of translational regulation of TCTP and have produced evidence that the mRNA of TCTP is highly structured. The mRNA binds to and activates PKR, resulting in its own translational inhibition (Bommer et al., 2002) . These studies also revealed that under serum deprivation TCTP levels are downregulated in a PKR-dependent manner. Here, we extend these studies by examining whether other cell-stress conditions result in PKRdependent regulation of TCTP expression, and whether TCTP levels influence the susceptibility of cells to various inducers of apoptosis. Our results show that conditions, which interfere with cellular calcium homeostasis, lead to downregulation of TCTP levels. This requires the presence of active PKR and intact eIF2a phosphorylation. We also establish that TCTP is active in diminishing the effects of various apoptotic inducers, including agents that cause disturbances in Ca þ þ homeostasis. These data suggest that PKR exerts its proapoptotic effects at least in part by inhibiting the expression of antiapoptotic proteins such as TCTP.
Results

TCTP is downregulated under Ca
þ þ -stress conditions in a PKR-dependent manner PKR is a proapoptotic kinase and downregulation of antiapoptotic proteins, such as TCTP, represents a potential mechanism by which PKR might facilitate apoptosis. In extension of our previous study (Bommer et al., 2002) , we have asked whether TCTP is regulated by PKR under proapoptotic conditions other than serum starvation. We assessed TCTP levels by western blotting using mouse-embryo fibroblasts (MEFs) from PKR-knockout and control mice after treatment with the following proapoptotic stimuli: sodium arsenite, which causes oxidative stress (Chen et al., 1998) and induces eIF2a phosphorylation (Lu et al., 2001) ; Ca þ þ ionophore A23187, an agent that leads to calcium influx; and thapsigargin, an inhibitor of the calcium pump in the ER membrane. We also employed tunicamycin, an inhibitor of protein glycosylation, which causes another ER stress. We also included serum starvation (Figure 1a) , which is known to downregulate TCTP levels in a PKR-dependent manner (Bommer et al., 2002) . The results in Figures 1a and b demonstrate that TCTP is downregulated in wild-type cells, specifically under conditions that perturb cellular Ca þ þ homeostasis, but not in response to tunicamycin or sodium arsenite. In contrast, in PKR-knockout cells TCTP levels are largely unaffected under any of these conditions, indicating that PKR is required for downregulation of TCTP levels under Ca þ þ -stress conditions. The fact that tunicamycin and sodium arsenite were unable to downregulate TCTP in wild-type cells, in spite of being activators of PKR and inducers of eIF2a phosphorylation (Ito et al., 1999; Patel et al., 2000) , suggests that PKR-mediated phosphorylation of eIF2a is not sufficient to affect TCTP expression and that an additional Ca þ þ -stress-dependent step is involved. Recently, it has been established that PKR is an important downstream effector of p53 in the induction of apoptosis (Yoon et al., 2009) . To determine whether this pathway is also able to regulate the expression of TCTP, we made use of a pair of mouse erythroleukaemia cells expressing either a temperature-sensitive mutant form of p53 or a non-activatable mutant p53 (Constantinou and Clemens, 2007) . Our results (Figure 2a ) clearly show that activation of p53 results in downregulation of TCTP levels, similar to the effects of cellular Ca þ þ -stress conditions (Figure 1 ). Phosphorylation of eIF2a has been shown to be important for PKR-dependent apoptosis (Garcia et al., 2006; Scheuner et al., 2006) . However, since PKR is also involved in other apoptosis-regulating pathways, it was of interest to establish whether eIF2a phosphorylation is indeed essential for downregulation of TCTP under Ca þ þ stress. To this end, we used MEFs from eIF2a-mutant (S51A) knock-in mice and from the corresponding wild-type animals, and subjected them to Ca þ þ ionophore, thapsigargin and tunicamycin treatments. The results (Figures 2b and c) confirm that, in wild-type MEFs, TCTP levels are strongly downregulated under Ca þ þ -stress conditions, but undergo only limited changes in response to tunicamycin. However MEFs with defective eIF2a phosphorylation do not display downregulation of TCTP levels under any of the conditions tested. Collectively, our results suggest that eIF2a phosphorylation is necessary, although not sufficient, for downregulation of TCTP levels.
Participation of PKR in apoptosis induction by a wide variety of stimuli is well established, but it was important to demonstrate that PKR is indeed involved in the induction of apoptosis under our specific stress conditions. To this end, we measured caspase-3 activity in extracts from PKR-knockout cells in comparison with their wild-type counterparts after treatment with ), and the non-activatable mutant, p53 (Pro 190 ), were kept at 38 1C prior to shifting to the permissive temperature (32 1C) for the indicated periods of time. Cell extracts were prepared and western blots were performed for TCTP and for b-tubulin as a loading control. The graph shows quantified data from a representative of two experiments. (b) MEFs derived from eIF2a S51A-mutant, 'knock-in' mice and from control animals were subjected to the following cell-stress conditions: 5 mM Ca þ þ ionophore A23187, 0.4 mM thapsigargin or 2.5 mg/ml tunicamycin. Cells were harvested after the indicated periods of time and the relative TCTP levels were assessed as in Figure 1 . Example western blots showing TCTP and b-tubulin signals for both wild-type and eIF2a S51A cells. (c) Graphs of quantified data from a representative of two independent experiments (open symbols: cells from eIF2a S51A-knock-in mice; filled symbols: cells from wild-type mice).
the cell stresses described in Figure 1 . We used an assay using the caspase-3-specific, fluorogenic substrate Ac-DEVD-AMC. The results (Figure 3 ) demonstrate that all of the stress conditions applied result in raised caspase-3 activity, compared with that in serumstimulated cell extracts. Most stimuli required the presence of PKR for caspase-3 activation. (The low levels of caspase-3 activity in the A23187-treated cells are likely due to the osmotic activity of A23187, leading to premature cell lysis.) In contrast, albeit being a strong inducer of apoptosis, arsenite does not seem to require PKR activity to stimulate caspase activity (Figure 3 ). In additional experiments using PARP cleavage as a measure for caspase activation, we observed limited degree of protection against apoptosis induction by arsenite in PKR-knockout as compared with that in control cells (results not shown). This suggests a role for PKR in apoptosis induction by arsenite as well. However, the protective effect by PKR knock out or TCTP overexpression (see also Figure 6 below) against arsenite is very limited.
Relationship of TCTP levels to apoptosis induction in cells under Ca
þ þ -and other stress conditions The selective downregulation of TCTP levels in response to Ca þ þ stresses, but not to tunicamycin or arsenite (Figures 1 and 2) , suggests a possible role for TCTP in protecting cells against damage caused by perturbations of Ca þ þ homeostasis. PKR may promote apoptosis by downregulating such cytoprotective proteins. This hypothesis is supported by the fact that TCTP itself displays Ca þ þ -binding activity (reviewed by Feng et al., 2007) . In order to test this, we have investigated whether overexpression of TCTP can delay the execution of apoptosis induced by the cell-stress conditions applied here.
We made use of a TCTP-overexpressing cell line, and a corresponding vector-control cell line, derived from MAC-T bovine mammary epithelial cells. These cells were developed earlier to characterize the microtubulebinding and microtubule-stabilizing activity of TCTP (Gachet et al., 1999) . Figure 4a demonstrates that in the TCTP-overexpressing cell line the levels of this protein are about 1.4-fold, compared with that in healthy control cells. However, they are no longer subject to stress-dependent downregulation. We subjected these cells to serum starvation, tunicamycin, thapsigargin or sodium arsenite treatment. The corresponding cell extracts were subsequently assayed for caspase-3 activity. The results in Figure 4b show that overexpression of TCTP does indeed result in reduced apoptotic response, as judged by lower caspase-3 activity levels, under all conditions except treatment with arsenite. The protective effect of TCTP overexpression is most pronounced in thapsigargin-treated cells, indicating potential involvement of TCTP in the protection of cells against induction of apoptosis by agents that interfere with intracellular Ca þ þ homeostasis. TCTP also inhibited apoptotic response to tunicamycin to a significant extent, even though the endogenous protein was not downregulated by this agent (Figure 1b) . The observation that TCTP overexpression has a protective effect when apoptosis is induced by such a range of stimuli (including etoposide), suggests that this protein can exert a general antiapoptotic effect, at least when it is present in cells at high levels.
To confirm the antiapoptotic potential of TCTP by an independent method, we used a nuclear fragmentation assay, using propidium iodide (PI) staining of cells followed by fluorescence-activated cell sorting analysis. In this assay, cells with reduced (sub-G1) DNA content represent apoptotic cells (Spector et al., 1998) . TCTPoverexpressing and control cells were subjected to treatment with thapsigargin, tunicamycin or etoposide for up to 30 h and assayed for DNA content. Since arsenite is a very strong inducer of apoptosis, its effects occur much earlier, compared with that of the other inducers. Therefore, instead of arsenite, we included etoposide as an alternative apoptosis-inducing agent, against which protection of cells by TCTP overexpression has been demonstrated previously (Li et al., 2001) . Typical examples of scatter plots are shown in Figure 5a . Time courses for all three treatments and both cell lines are shown in Figure 5b response to different apoptosis inducers. To overcome this problem we employed a further approach, that is, time-lapse video microscopy. We subjected TCTP-overexpressing and control cells to the same treatments as described in Figure 5 , and monitored the kinetics of apoptosis induction. For each treatment, 40 cells were tagged and scored for the time at which they underwent visible transition to apoptotic morphology. The results of a typical data set (out of three experiments) are shown in Figure 6 . As in previous experiments, treatment with arsenite had the strongest apoptosis-inducing effect, with almost all cells undergoing apoptosis by 10-15 h. There was no substantial difference between the two cell lines, confirming the observation in Figure 4b . In contrast, treatment with thapsigargin resulted in a much slower induction of apoptosis: Only after about 40 h had all cells undergone apoptosis. In this case there was a clear delay in the kinetics of cell death in the TCTPoverexpressing as compared with that in the control cells, most notable in the 20-to 35-h period. The most dramatic delay in apoptosis in the TCTP-overexpressing cells was observed after treatment with 0.5 mM etoposide, lasting from about 10 to 40 h. Treatment with tunicamycin resulted in relatively slow kinetics of apoptotic cell death, as judged by this assay. Some protection by TCTP overexpression was observed during the first 25 h, but the low numbers of apoptotic cells make it difficult to determine whether this was significant. From these video microscopy results we conclude that overexpression of TCTP delays execution of apoptosis induced by thapsigargin or etoposide, but not that induced by arsenite.
Discussion
In a previous study, we have shown that TCTP is translationally regulated by PKR under serum starvation conditions (Bommer et al., 2002) . In the light of the well-documented role of PKR in apoptosis and the reported antiapoptotic activity of TCTP, it was important to investigate the role of PKR in the regulation of TCTP levels under apoptotic conditions in more detail. Here we have studied the relationship between TCTP expression and regulation of apoptosis, and have addressed particularly the role of protein kinase PKR and phosphorylation of eIF2a in the response of cells to various proapoptotic stimuli.
Regulation of TCTP levels by PKR in Ca
þ þ -stress conditions Several previous studies have shown that PKR activation and eIF2a phosphorylation are important in the regulation of apoptosis. However eIF2a phosphorylation can have a protective effect against a variety of cell stresses and can aid cell survival under some circumstances (Harding et al., 2000) . Moreover, PKR has other substrates besides eIF2a. It was, therefore, important to examine whether the PKRdependent regulation of TCTP levels requires eIF2a phosphorylation.
In addition to its effect on general protein synthesis, PKR can inhibit the translation of specific mRNAs (Davis and Watson, 1996; Ben-Asouli et al., 2002) , including one that encodes TCTP itself (Bommer et al., 2002) . This may happen because some mRNAs with extensive secondary structure are able to activate the kinase in a localized manner. In order to gain further insight into the role of PKR in regulating TCTP levels under proapoptotic conditions, we studied the regulation of TCTP levels in PKR-knockout cells under various stress conditions and observed PKR-dependent downregulation of the protein under Ca þ þ -stress conditions. An involvement of PKR in cellular reactions to Ca þ þ stress was suspected earlier (Brostrom and Brostrom, 1998) , and it was recently demonstrated that ER stresses activate PKR (Lee et al., 2007) . . Both cell lines were either left untreated or subjected to cell stress (17 h 0.5 mM sodium arsenite) and were assessed for relative TCTP levels by western blotting. (b) TCTP overexpression inhibits induction of apoptosis. Both cell lines were subjected to the following cell-stress conditions for 18 h: 2.5 mg/ml tunicamycin, 0.8 mM thapsigargin or 0.2 mM sodium arsenite. Serum-starved (24 h) and serum-stimulated cells (6 h 20% fetal calf serum after 24 h of serum starvation) were included as controls. Cell extracts were assayed for caspase-3 activity using the fluorogenic substrate Ac-DEVD-AMC. The activity is expressed as relative fluorescence units (RFUs) per microgram of protein, measured during the first 2 h of the assay. The mean (with s.d.) from three independent experiments is plotted.
PKR has also been implicated in response to other cellular stresses (Garcia et al., 2006) . However, it is not clear why TCTP levels are selectively downregulated under some conditions (Ca þ þ stress and activation of p53) but not others. Moreover, while regulation of TCTP under Ca þ þ -stress conditions can be reconciled with a presumptive function of TCTP as an antiapoptotic Ca þ þ -scavenger protein (Graidist et al., 2007) , our results indicate that PKR activity is necessary, but not sufficient, to achieve TCTP downregulation under these conditions.
Our results indicating p53 as part of the pathway that regulates TCTP levels (Figure 2a) , are in line with an earlier report concerning p53-dependent regulation of TCTP levels (Tuynder et al., 2002) . They clearly establish TCTP as a target for the p53 pathway and underscore the necessity of TCTP downregulation for initiation of apoptosis. Ca þ þ -stress-mediated downregulation of TCTP is dependent on PKR (Figure 1 ) and also on phosphorylation of eIF2a (Figures 2b  and c) . The latter result is in line with the demonstration that eIF2a phosphorylation is required for apoptosis induction (Scheuner et al., 2006) . Consistent with the results obtained using the PKR À/À cells, the data from experiments with the eIF2a S51A-knock-in cells (Figure 2c) show that TCTP levels are substantially downregulated under Ca þ þ -stress conditions, but only to a much lesser extent by tunicamycin. Also, with tunicamycin treatment there was only a minimal difference in the effect on TCTP levels between the eIF2a-mutant cells and their controls. In response to thapsigargin and Ca þ þ ionophore, while wild-type cells reacted with a substantial downregulation of TCTP levels, the mutant cells showed a small, initial upregulation of TCTP levels (Figure 2c ). This suggests that there are mechanisms that can upregulate TCTP as a cytoprotective reaction, but that these are overridden by PKR activation and eIF2a phosphorylation when the proapoptotic signal is strong enough. An earlier report on the regulation of TCTP levels in simian Cos-7 cells did indeed note an upregulation of TCTP in response to A23187 and thapsigargin (but not tunicamycin) treatment, and this upregulation occurred at both the transcriptional and translational level (Xu et al., 1999) .
The translation of TCTP mRNA is specifically inhibited by PKR (Bommer et al., 2002) ; this may provide an explanation for the PKR dependence of the regulation of TCTP in cells in response to thapsigargin and A23187 (Figure 1) . However, the relative lack of effect of sodium arsenite and tunicamycin (Figures 1 and 2) , which also promote eIF2a phosphorylation (Lu et al., 2001; Lee et al., 2007) , suggests that phosphorylation of eIF2a, although necessary, is not sufficient for TCTP downregulation.
Indeed, PKR activation alone may not be enough to result in loss of TCTP, since arsenite is also a well-documented activator of PKR (Ito et al., 1999; Patel et al., 2000) . Taken together, our data favour a model in which PKR activation, eIF2a phosphorylation and an additional signal related to Ca 2 þ stress are required for reduction in TCTP expression (Figure 7) .
The role of TCTP as an antiapoptotic protein under Ca þ þ -stress conditions The possibility that TCTP exerts its antiapoptotic effect especially under conditions of perturbed Ca þ þ homeostasis, is attractive, since TCTP itself has been reported to be a Ca þ þ -binding protein (Feng et al., 2007; Graidist et al., 2007) . We, therefore, asked whether TCTP is active in protecting cells from apoptosis induction by perturbation of intracellular Ca þ þ , as compared with other cell stresses. Our results show that overexpression of TCTP does indeed delay the execution of apoptosis induced by a variety of agents. However, this protection is not specific to perturbation of Ca þ þ homeostasis (Figures 4-6 ). Interestingly, TCTP overexpression also resulted in clear protection of cells against apoptosis induction by tunicamycin in some assays (Figures 4 and 5) , although only to a limited extent in a different assay (Figure 6 ).
It has been suggested that TCTP acts as an intracellular Ca þ þ scavenger (Graidist et al., 2007) . Our observations on both the pattern of PKR-dependent downregulation of TCTP under Ca þ þ -stress conditions and on the cytoprotective function of TCTP 6 ) also suggest that the protein has broader antiapoptotic effects. Several reports support the view that TCTP undergoes direct interactions with the apoptotic machinery (Zhang et al., 2002; Liu et al., 2005; Yang et al., 2005; Susini et al., 2008) The antiapoptotic protein Bcl-xL, with which TCTP interacts, is involved in maintaining Ca þ þ homeostasis in the ER (Xu et al., 2005) and it is, therefore, possible that involvement of TCTP in the cell's response to Ca þ þ stress is based on this interaction.
It was recently reported that translational downregulation of another antiapoptotic protein, Mcl-1, is an important permissive step in the apoptotic events induced by cell-stress reagents such as tunicamycin, thapsigargin and arsenite (Fritsch et al., 2007) . Reduction in Mcl-1 levels requires phosphorylation of eIF2a. This situation is strikingly similar to the one described here for TCTP. Interestingly, Mcl-1 has been described as a protein stabilizing TCTP (Zhang et al., 2002) and vice versa (Liu et al., 2005) . These results are compatible with a model according to which activation of PKR by proapoptotic stimuli results in an increase in eIF2a phosphorylation and downregulation of antiapoptotic proteins (Scheuner et al., 2006) , such as TCTP (Figure 7) or Mcl-1 (Fritsch et al., 2007) . It will be important to investigate which other antiapoptotic proteins may be regulated in this way.
Materials and methods
Cell lines and tissue culture Cells were grown in Dulbecco's Modified Eagle's Medium containing 10% fetal calf serum, penicillin, streptomycin and added non-essential amino acids at 37 1C, in the presence of 5% CO 2 . MEFs from PKR-knockout mice (PKR À/À cells) and from the corresponding wild-type mice (PKR þ / þ cells), provided by the laboratory of Dr C Weissmann, were cultivated with the addition of 0.1 mM b-mercaptoethanol. Cultivation of mouse erythroleukaemia cells was performed as described earlier (Constantinou and Clemens, 2007) . MEFs from mutant eIF2a (S51A)-knock-in mice and from wild-type animals were kindly provided by Drs D Scheuner and R Kaufman. Bovine mammary epithelial (MAC-T) cells overexpressing TCTP and the corresponding vector-only control cells (Gachet et al., 1999) were cultivated in Dulbecco's Modified Eagle's Medium with additional insulin (5 mg/ml) and hygromycin-B (50 mg/ml). For preparation of extracts, cell pellets were lysed in 2 volumes of lysis buffer (10 mM HEPES (pH 7.3), 2 mM EDTA, 0.1% NP40, 5 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride, 10 mg/ml pepstatin-A, 20 mg/ ml leupeptin, 10 mg/ml aprotinin). The lysates were centrifuged at 4 1C for 10 min at 15 000 r.p.m. Supernatants were stored at À80 1C and protein concentrations were determined by Bradford assay.
Western blotting
To assess TCTP protein levels, equal amounts (12 mg protein) of cell extracts were separated by sodium dodecyl sulphate gel electrophoresis on 12.5% polyacrylamide gels and electrotransferred onto polyvinylidene difluoride membranes. Blots were blocked in 3% block milk and incubated with primary antibody at 4 1C overnight. Anti-TCTP (P23) antibodies were described earlier (Gachet et al., 1999) . After washing, the blots were incubated with secondary antibody (anti-rabbit IgG; Dako, Glostrup, Denmark, or anti-mouse IgG; Sigma, Poole, Dorset, UK). Antibodies were detected using the ECL Plus kit (Amersham Biosciences, Amersham, Bucks, UK). Images were captured using a ChemImager Ready system (Alpha Innotech Corp, San Leandro, CA, USA) equipped with a CCD camera. Protein bands were quantified using the Fluorchem software (Alpha Innotech). Blots were reprobed with a monoclonal anti-b-tubulin antibody (Amersham) and the TCTP band intensities were corrected for the corresponding tubulin signal.
Assays of caspase-3 activity After cell treatment, cells were harvested by trypsinization, washed twice in ice-cold phosphate-buffered saline and lysed in lysis buffer as described above. Caspase-3 activity was assayed using the fluorogenic substrate Ac-DEVD-AMC (Biosource International). 30 mg of cell extract (in 20 ml lysis buffer) was diluted into 200 ml of reaction buffer (100 mM HEPES pH 7.3, 0.5 mM EDTA, 20% glycerol, 5 mM dithiothreitol) and 2 ml of substrate (5 mM Ac-DEVD-AMC) was added. Reactions were incubated at 37 1C and product formation was measured by fluorescence (excitation: 380 nm; emission: 460 nm) using a Fusion microplate reader (Packard Biosciences) at hourly 
Genotoxic cell stress
Figure 7 A proposed model of the involvement of PKR and eIF2a phosphorylation in the downregulation of TCTP and induction of apoptosis in response to physiological stress conditions. The model summarizes the conclusions described in the text. In particular, it is suggested that activation of PKR and the consequent phosphorylation of eIF2a are necessary conditions for downregulation of TCTP by Ca þ þ stress or by activation of p53, which is known to be induced by genotoxic stress. Loss of TCTP may be mediated by PKR-dependent inhibition of the translation of its mRNA.
A further signal appears to be required for downregulation of TCTP by Ca þ þ stress. Since TCTP performs a cytoprotective role by inhibiting cell death, loss of TCTP may contribute to the proapoptotic effects of p53 and PKR activity. Similar mechanisms may downregulate other antiapoptotic proteins, leading to enhancement of apoptosis in response to a variety of physiological stresses.
intervals. Caspase-3 activity was expressed in relative fluorescence units (RFU) per mg of protein.
DNA flow cytometry
Cells were examined for DNA content by PI staining and subsequent flow cytometry (Spector et al., 1998) . After drug treatment, cells were trypsinized, washed twice with ice-cold phosphate-buffered saline and resuspended in 0.5 ml phosphate-buffered saline (10 6 cells per sample). 5 ml of ice-cold ethanol was added dropwise under vortexing and cells were fixed at 4 1C overnight. Fixed cells were collected, washed twice with phosphate-buffered saline, stained with PI (500 mg/ ml) and incubated with RNase A for 30 min at 37 1C. The stained cells (20 000 events per sample) were assayed with a Beckton Dickinson LSR II flow cytometer (BD Biosciences Immuno-Cytometry Systems, San Jose, CA, USA) using the configuration for detecting PI and the BD FACSDiva software. Data were analysed with the FlowJo programme (Tree Star Inc., Ashland, OR, USA). The cells were gated to exclude fragmented and aggregated cells, and the results were plotted as pulse area (DNA content, PI-A, x-axis) versus pulse width (particle size, PI-W, y-axis), and the proportions of cells with reduced amount of DNA (sub-G1) were estimated and scored as apoptotic cells (see Figure 5 ).
Time-lapse cell-video microscopy MAC-T cells overexpressing TCTP and vector-control cells were cultured in 12-well plates and treated under various cellstress conditions. Cells were photographed under phasecontrast using an Olympus IX70 inverted microscope equipped with a Hamamatsu C4742-95 digital camera at 15-min intervals for time periods up to 72 h. Both the microscope and camera were enclosed within a heated chamber (Solent Scientific, Segensworth, UK) at 37 1C under 5% CO 2 . Cell movies were analysed using the ImageJ software (http://rsb.info.nih.gov/ij). Forty cells per field of view were randomly identified at time point 0 h and tracked along the time course of the experiment. The time at which each cell displayed clearly visible apoptotic alterations was scored. Apoptotic morphology was defined by cell shrinkage and by a change to a bright appearance under phase contrast. The percentage of apoptotic cells within the scored cell population was plotted against time.
